The smoking habits of 50 proved cases of chronic bronchitis were studied. Bronchoscopy was done and a bronchial biopsy was taken for histological examination. Bronchial lavage was obtained under sterile conditions for bacteriological studies. The degree of bronchial mucous gland hypertrophy was determined, and the presence or absence of infection, as shown by the presence of potential pathogens in the bronchial lavage, was noted. We think that tobacco smoking and its resulting irritation to the bronchi is the most important underlying cause of bronchial mucous gland hypertrophy because there is: (1) a significantly higher incidence of mucous gland hypertrophy in smokers than in non-smokers among the 50 chronic bronchitics studied; (2) a significantly higher accumulated lifetime tobacco consumption in patients exhibiting mucous gland hypertrophy than in those without hypertrophy of the bronchial mucous glands; (3) a significant association and correlation between the degree of mucous gland hypertrophy and the intensity of smoking; and (4) no difference in the comparative frequency of occurrence of bronchial mucous gland hypertrophy in subjects with and without demonstrable infection, as shown by the presence of potential pathogens in the bronchial lavage. We could not deny that infection might be having an initiating or potentiating effect.
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The characteristic feature of chronic bronchitis is an excessive secretion of mucus, which provokes cough and expectoration. This mucus secretion is mainly a function of the bronchial mucous glands. Glynn and Michaels (1960) , Reid (1960) , and Restrepo and Heard (1963a, b) demonstrated enlargement of the mucous glands in chronic bronchitis. Glynn and Michaels (1960) showed that the pathological features consisted of an increase both in the number of mucous relative to serous glands and in the size of the mucous acini due to swelling of their component cells and their lumina. They suggested that this mucous change is probably the result of transformation of serous into mucous acini, followed by an increase in size of the latter. They considered that this mucous change of the deep glands is the most important pathological feature of chronic bronchitis. Reid (1960) found that the amount of sputum produced by the chronic bronchitic was well correlated with the degree of mucous gland hypertrophy. To investigate the role of smoking in inducing this mucous gland hypertrophy, Thurlbeck, Angus, and Pare (1963) examined bronchi from necropsies and grouped cases according to smoking habits. They found that the Reid gland: wall ratio was significantly higher in heavy smokers than in non-smokers.
The aim of the present work was to study the correlation between the degree of hypertrophy of the bronchial mucous glands, as shown by bronchial biopsies obtained from chronic bronchitics, and the smoking habits of these patients or the presence of infecting pathogens in the bronchial tree, in an attempt to evaluate the roles of tobacco irritation and infection in the production of this mucous change in the bronchial glands.
METHODS AND MATERIALS
Fifty men with chronic bronchitis admitted to the Medical Department, Cairo University Hospitals, constitute the subject of the present study. This confinement to the male sex was not due to selection on our part, for in the period from October 1962 to May 1964, Masters, Brumfitt, Mendez, and Likar (1958) and Laurenzi, Potter, and Kass (1961) . Brumfitt, Willoughby, and Bromley (1957) had found that normal bronchi swabbed directly through a bronchoscope were sterile, whereas Haemophilus influenzae was isolated from 18 of 19 chronic bronchitics. A loopful of the bronchial lavage obtained was inoculated on to duplicate plates of blood agar, one of which was inoculated aerobically and the other anaerobically at 370 C. After 24 hours' incubation plates were examined for growth. All organisms were identified by visual examination and smear. Staphylococci were tested for ability to produce coagulase by the tube method using rabbit antiserum. All coagulase-positive strains were recognized by the production of haemolysin on blood agar plates. Pneumococci were injected into mice and the postmortem picture was studied. Strains of H. influenzae were identified by their morphology and indole production. Gram-negative rods were identified by subculture on differential media and biochemical reaction.
H. influenzae, Staphylococcus aureus, and pneumococci were considered to be the most important potential pathogenic organisms for the bronchi, as reported by Dowling, Mellody, Lepper, and Jackson (1960) and Cherniack, Vosti, Dowling, Lepper, and Jackson (1959) . Neisseria catarrhalis, diphtheroids, and streptococci of the viridans and indifferent varieties were ignored. Streptococci of the Pl-haemolytic variety and Klebsiella pneumoniae, although of lesser importance and occurring less frequently, were also considered as potential pathogens. Our 50 chronic bronchitics were then classified into two groups:
Group A This group comprised 28 patients. Any one or more of the potentially pathogenic organisms was isolated from the bronchial lavage.
Group B This group consisted of 22 patients. Infection of the bronchial tree could be excluded because none of these pathogens was present in the bronchial lavage.
Bronchoscopic biopsy was taken with a Brock's biopsy forceps under vision from the main carina. The specimens obtained were fixed in 10% formalin solution, embedded in paraffin, and cut at 5 IA intervals.
A record of the main histological features in each case was made without knowledge of the clinical history or smoking habit of the patient. Broncho-scopic biopsies were also taken in the same way from five normal adult males, and were stained and used as controls in assessing variations seen in the biopsy materials. The ages of these control subjects were 30, 39, 47, 54, and 60 years respectively.
The 50 cases studied were graded according to the state of the bronchial mucous glands as follows:
Grade 0 No mucous glands or only a small number of normal mucous glands were seen in the sections examined. This group comprised 15 patients. In two of these, serous glands predominated, with a small number of normal mucous glands. In three patients a small number of serous glands only were seen in the sections. In the remaining 10 patients no serous or mucous glands were present in the sections examined.
Grade I Only a slight increase in the number of mucous glands was seen. This group comprised four patients.
Grade 2 An increase in the number of mucous glands was obvious, with numerous serous acini and demilunes. This group comprised nine patients.
Grade 3 The mucous glands were found to be hypertrophied and of greater diameter than normal.
The cells of the acini were taller and wider and their cytoplasm less basophilic. The cells were also overdistended with mucus rather than showing an excessive discharge into the lumen, but occasionally a mucous discharge in the lumen was present and the gland therefore appeared as small flat cells enclosing a lumen filled with mucus. In addition, a few serous acini and demilunes were found. This group comprised 15 patients.
Grade 4 Hypertrophied mucous glands, as described in grade 3, were seen, but with complete replacement of the normally predominant serous glands, so that there were no serous glands or demilunes as in grade 3. This group comprised seven patients (Figs 1 and 2) .
It is worth noting that the five normal control subjects showed no evidence of developing either hypertrophy or atrophy of the bronchial mucous glands with age. smokers (43) and non-smokers (7) in the 50 cases of chronic bronchitis studied, using Fisher's exact test for 2 x 2 tables, has shown a significantly higher incidence of mucous gland hypertrophy in smokers (77 %) than in non-smokers (29 %), P= 0-02, as shown in Table I . In fact out of the 35 cases showing mucous gland change, only two patients were non-smokers, and it is of interest to note that both were workers in dusty occupations, the first an agricultural labourer and the second a labourer on unpaved dusty high roads in the countryside.
To study the relation between the degree of mucous change of the bronchial glands and the degree of intensity of the smoking habit, we compared statistically the average accumulated lifetime tobacco consumption of patients showing mucous gland hypertrophy with that of patients in whom no change was detected in the bronchial glands, using Student's 't' test. It was found that the average accumulated lifetime tobacco consumption among patients with mucous gland hypertrophy (33 cases)-275,000 cigarettes, S.D. 194,000-was significantly higher than among patients in whom no such hypertrophy was observed (10 cases)-133,000 cigarettes, S.D. 106,000-P<0-05.
As a further study of the association between the degree of mucous change of the bronchial glands and the degree of intensity of the smoking habit, we used the chi-square test. We compared the relative frequency of incidence of marked mucous change in the bronchial glands (grades 3 and 4 of our classification) in non-or light smokers (grades 0 and 1 of our classification-those whose accumulated lifetime tobacco consumption was found to be less than 200,000 cigarettes) and in heavier smokers-those who smoked more than 200,000 cigarettes (grades 2, 3, and 4 of our classification to its incidence (68 5 %) in the 22 patients with no pathogens cultured from the bronchial lavage.
This difference in incidence is insignificant, and the two groups are almost identical.
To study the role of infection further, and whether it potentiates the effect of smoking, Table III was constructed. We compared the incidence of bronchial mucous gland hypertrophy in patients who smoked more and less than 40,000 cigarettes, among patients in whom infection of the bronchial tree was or was not found. The level of significance of the comparative frequency of incidence of bronchial mucous gland hypertrophy in the compared groups was calculated using Fisher's exact test for 2 x 2 tables. This pair of tables shows that whether infection was or was not found, the incidence of mucous gland hypertrophy was significantly higher in those who smoked more than 40,000 cigarettes than in those who smoked less than this amount. This also shows that those who smoked more than 40,000 cigarettes had a similar incidence of hypertrophy of the mucous glands, whether infection was or was not present, i.e., the incidence of mucous gland hypertrophy was not affected by the presence or absence of infection as shown by the next pair of tables (Table IV) . Although this table does not show statistically significant evidence that in patients who smoked less than 40,000 cigarettes infection has a potentiating effect, yet the apparent effect is potentiation. Mucous gland hypertrophy was observed in 28-5% of patients (two out of seven) when infection was found. When no infection was found (four patients) no case showed mucous gland hypertrophy. This apparent potentiating effect of infection cannot be dismissed simply because the number of patients in this group is small. The fact that the effect of infection is nonsignificant does not permit infection to be dismissed, for non-significance does not mean nonexistence. In order to dismiss infection as a factor one would need a confidence integral for a parameter which describes the effect of infection, and would need to show that only a negligible effect is compatible with the observations. However, suppose that one writes: p1=probability that the mucous glands are normal in an infected light or non-smoker p,=probability that the mucous glands are normal in an uninfected smoker p3= probability that the mucous glands are normal in an infected smoker Then consider the evidence for or against the following hypothesis: P3 =PlP2 (i.e., smoking and infection act independently) Tables III and IV can be rearranged as a table  of the incidence of normal mucous glands, as  follows:   CIGAREITE CONSUMPTION   <40,000  >40,000  Infection  5/7=0-71  3/21=0-14 No infection 4/4=l100 3/18=0-17
The data suggest that hypertrophy is rare when both infection and heavy smoking are absent, and that Pi = 071, P2 0.17. These two values give pip,=0 12, giving an expectation of 2-52 normal cases in the 21 infected heavy smokers according to the hypothesis P3=PiP2. The observed number is three (i.e., 14% against the theoretical 12%), which agrees well with the hypothesis. Therefore one should not dismiss infection as an associated aetiological agent.
DISCUSSION
The present study clearly shows that smoking is an important underlying aetiological basis for the mucous gland hypertrophy seen in chronic bronchitics as evidenced by:
(1) the significantly higher incidence of mucous gland hypertrophy in smokers than in nonsmokers among the 50 chronic bronchitics studied. In fact, out of the 35 cases with mucous gland hypertrophy only two, i.e., 5 7%, were nonsmokers. These two patients were found to be labourers in dusty occupations, where the irritation of inhaled dust replaced the irritation of inhaled tobacco smoke in producing mucous gland hypertrophy;
(2) the significantly higher average accumulated lifetime tobacco consumption in patients with mucous gland hypertrophy than in those without such a change; (3) the significant association between the degree of mucous change of the bronchial glands and the intensity of the smoking habit as shown by the chi-square test; (4) the significant correlation between the degree of mucous gland hypertrophy and the degree of intensity of the smoking habit, as measured by the daily or accumulated lifetime tobacco consumption.
Since we obtained histological material from each patient on a single occasion only, we cannot state whether the glandular hypertrophy that we studied is permanent or reversible. If the hypertrophy is irreversible, it may be argued that there will tend to be more hypertrophy in persons with a large total of cigarettes smoked, simply because this total is also irreversible, that is, hypertrophy and the total smoking will tend to have a positive correlation because both tend to be higher in older than in younger people. To answer this argument, the average age of smokers with bronchial mucous gland hypertrophy (33 cases) was found to be 49-3 years (S.D. 109), and the average age of smokers with no mucous gland hypertrophy (10 cases) 42-7 years (S.D. 12). The difference of 6-6 years between the two means, however, tested by the 't' test proved to be insignificant (p 0-1). Similarly, a calculation of 95% confidence limits for the true mean age of both groups of smokers with or without bronchial mucous gland hypertrophy was carried out. The 95% confidence interval of the true mean age for smokers with mucous gland hypertrophy was found to be from 45-43 years to 53-17 years, and for smokers with no mucous gland hypertrophy from 34-12 to 51-28 years. The difference in true mean ages may be as large as 19 years in one direction or, alternatively, as much as 5 85 years in the opposite direction. The usual theory of confidence limits is a little shaky on data such as these, but the essential point is that although the observed difference (6-6 years) is not significant one cannot discount the existence of a real difference in the same direction. The question, however, is whether hypertrophy tends to increase with age so fast that the difference of 6-6 years can account for the observed differences in the incidence of bronchial mucous gland hypertrophy. Our five normal control subjects showed no evidence of either hypertrophy or atrophy of the bronchial mucous glands developing with age.
We similarly compared the incidence of bronchial mucous gland hypertrophy, using contingency tables based on two dividing lines for the ages of the patients, namely, 45 and 55 years, and applied Fisher's exact test for 2 x 2 tables, to find if there was any significant difference in the incidence of mucous gland hypertrophy above and below these dividing lines (Table V) . The differences again were found to be not significant. That chronic bronchitis observed during the period of this study was confined (without selection on our part) to the male sex is also further evidence in favour of the role of smoking. In our country, smoking is very rare in women and is almost unknown in our hospital class of female patients.
Our findings are in agreement with the necropsy study of the bronchi carried out by Thurl-beck et al. (1963) , who grouped cases according to their smoking habits and found that the Reid (1960) gland: wall ratio was significantly higher in heavy smokers than in non-smokers. Glynn and Michaels (1960) found smoking to be more common (7 out of 16) among patients having mucous gland excess than in those with serous gland excess (2 out of 14). They commented, however, that information about smoking habits in their patients was incomplete and that it would be unwise to stress the difference between the two groups. They also could find no relation between smoking and the degree of mucous conversion, and suggested that tobacco is not the immediate cause of mucous change of the bronchial glands.
Since mucous gland hypertrophy, as suggested by Glynn and Michaels (1960) , is the cardinal pathological feature in chronic bronchitis, the present study points to the importance of smoking as an aetiological factor in this disease. This agrees with the observations of Oswald and Medvei (1955) and Palmer (1954) that bronchitis is more common among smokers than nonsmokers.
The present study could not show that infection has a role in the causation of mucous change of the bronchial glands in chronic bronchitis. This may point to the greater importance of smoking as an aetiological factor in this disease and is in agreement with the views of Greene and Berkowitz (1954) , who reported smoking to be four to seven times more common a cause of chronic bronchitis than all other causes combined. In fact, in a study of the role of smoking in chronic bronchitis in Egyptians, one of us (G. E. M.) found by comparing the smoking habits of chronic bronchitics and control nonbronchitic subjects that a critical upper limit value of accumulated lifetime tobacco consumption equivalent to 300,000 cigarettes existed, above which all smokers were chronic bronchitics. This is equivalent to the smoking of two packets of cigarettes daily for 20 years. Yet one cannot completely rule out the role of infection, which might be having an initiating or potentiating effect that is difficult to ascertain on the basis of the present data.
